AU2004272066B8 - Methods of using WISP antagonists - Google Patents

Methods of using WISP antagonists Download PDF

Info

Publication number
AU2004272066B8
AU2004272066B8 AU2004272066A AU2004272066A AU2004272066B8 AU 2004272066 B8 AU2004272066 B8 AU 2004272066B8 AU 2004272066 A AU2004272066 A AU 2004272066A AU 2004272066 A AU2004272066 A AU 2004272066A AU 2004272066 B8 AU2004272066 B8 AU 2004272066B8
Authority
AU
Australia
Prior art keywords
wisp
antibody
cells
polypeptide
cartilage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004272066A
Other languages
English (en)
Other versions
AU2004272066B2 (en
AU2004272066A1 (en
Inventor
Luc Desnoyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU2004272066A1 publication Critical patent/AU2004272066A1/en
Publication of AU2004272066B2 publication Critical patent/AU2004272066B2/en
Application granted granted Critical
Publication of AU2004272066B8 publication Critical patent/AU2004272066B8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2004272066A 2003-09-11 2004-09-09 Methods of using WISP antagonists Ceased AU2004272066B8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50201303P 2003-09-11 2003-09-11
US60/502,013 2003-09-11
PCT/US2004/029510 WO2005025603A2 (en) 2003-09-11 2004-09-09 Methods of using wisp antagonists

Publications (3)

Publication Number Publication Date
AU2004272066A1 AU2004272066A1 (en) 2005-03-24
AU2004272066B2 AU2004272066B2 (en) 2010-07-29
AU2004272066B8 true AU2004272066B8 (en) 2010-08-05

Family

ID=34312341

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004272066A Ceased AU2004272066B8 (en) 2003-09-11 2004-09-09 Methods of using WISP antagonists

Country Status (6)

Country Link
US (1) US20060292150A1 (https=)
EP (1) EP1663288A2 (https=)
JP (1) JP2007505131A (https=)
AU (1) AU2004272066B8 (https=)
CA (1) CA2536396A1 (https=)
WO (1) WO2005025603A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7455834B2 (en) 2002-06-29 2008-11-25 Genentech, Inc. Methods and compositions for modulating and detecting WISP activity
ATE476447T1 (de) 2002-06-29 2010-08-15 Genentech Inc Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität
EP1937306B1 (en) * 2005-08-19 2016-02-17 Janssen Biotech, Inc. Proteolysis resistant antibody preparations
FR2900155B1 (fr) * 2006-04-21 2008-06-27 Diana Naturals Sa Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
KR102148303B1 (ko) 2012-02-11 2020-08-26 제넨테크, 인크. R-스폰딘 전위 및 그의 사용 방법
CA3025960A1 (en) * 2016-06-02 2017-12-07 Nestec S.A. Methods for treating sarcopenia and muscle injury

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062927A1 (en) * 1998-06-05 1999-12-09 Human Genome Sciences, Inc. Connective tissue growth factor-4
WO2002033085A2 (en) * 2000-10-16 2002-04-25 Genentech, Inc. Wisp polypeptides and therapeutical applications thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7610396A (en) * 1996-11-08 1998-06-03 Human Genome Sciences, Inc. Connective tissue growth factor-3
WO2001007085A1 (en) * 1999-07-23 2001-02-01 Case Western Reserve University Novel methods and reagents useful in the treatment of osteoarthritis
ATE476447T1 (de) * 2002-06-29 2010-08-15 Genentech Inc Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062927A1 (en) * 1998-06-05 1999-12-09 Human Genome Sciences, Inc. Connective tissue growth factor-4
WO2002033085A2 (en) * 2000-10-16 2002-04-25 Genentech, Inc. Wisp polypeptides and therapeutical applications thereof

Also Published As

Publication number Publication date
JP2007505131A (ja) 2007-03-08
WO2005025603A3 (en) 2006-04-27
EP1663288A2 (en) 2006-06-07
AU2004272066B2 (en) 2010-07-29
CA2536396A1 (en) 2005-03-24
US20060292150A1 (en) 2006-12-28
AU2004272066A1 (en) 2005-03-24
WO2005025603A2 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
US8138152B2 (en) Methods of treatment using WISP polypeptides
US20070212362A1 (en) Use of il-17 antibody for the treatment of cartilage damaged by osteoarthritis
US7732567B2 (en) Methods and compositions for modulating and detecting wisp activity
AU2004272066B2 (en) Methods of using WISP antagonists
JP4636497B2 (ja) Ｗｉｓｐ活性を調節し検出するための方法及び組成物
HK1112470B (en) Methods and compositions for modulating and detecting wisp activity

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 24, NO 30, PAGE(S) 3525 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME GENENTECH, INC., APPLICATION NO. 2004272066, UNDER INID (22) CORRECT THE FILING DATE TO 9.09.04

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired